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It is well known that blood vessels including arterioles have a perivascular innervation. It is also widely
accepted that perivascular nerves maintain vascular tone and regulate blood ﬂow. Although there are
currently prevailing opinions, uniﬁed views on the innervation of microcirculation in any organs have
not been established. The present study was designed to investigate whether there are perivascular
nerves innervated in microvessels and neovessels. Furthermore, we examined whether nerve growth
factor (NGF) can exert a promotional effect on perivascular nerve innervation in neovessels of Matrigel
plugs. A Matrigel was subcutaneously implanted in mouse. The presence of perivascular nerves in
Matrigel on Day 7e21 after the implantation was immunohistochemically studied. NGF or saline was
subcutaneously administered by an osmotic mini-pump for a period of 3e14 days. The immunostaining
of neovasculatures in Matrigel showed the presence of perivascular nerves on Day 21 after Matrigel
injection. Perivascular nerve innervation of neovessels within Matrigel implanted in NGF-treated mice
was observed in Day 17 after Matrigel implantation. However, NGF treatment did not increase numbers
of neovessels in Matrigel. These results suggest that perivascular nerves innervate neovessels as neo-
vasculatures mature and that NGF accelerates the innervation of perivascular nerves in neovessels.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
It is well recognized that blood vessels including arterioles,
except capillary vessels, have a perivascular innervation. It is also
widely accepted that perivascular nerves maintain vascular tone
and regulate organ and tissue blood ﬂow. With few exceptions, the
postganglionic adrenergic nerves constitute the most signiﬁcantFGF, basic ﬁbroblast growth
like immunoreactivity; NE,
opeptide Y; TH, tyrosine hy-
rotein Gene Product 9.5.
armacy, College of Pharma-
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. Takatori).
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d/4.0/).efferent neural pathway to the blood vessels and maintain the tone
(1). Although there are currently prevailing opinions, there are no
uniﬁed views on the innervation of the microcirculation in any
organs. There is a great diversity in the distribution and density of
the microvascular adrenergic innervation (2,3). The degree that
adrenergic nerves inﬂuence the control of microcirculation de-
pends, in part, on the pattern of distribution of these nerves to the
various vessels, which form the microvascular network (4). The
functional signiﬁcance of adrenergic neural control of the micro-
circulation varies among different organs and between different
segments of the microvascular network in any given tissue. Since
very few systematic studies have described the adrenergic inner-
vation of the microcirculation in any organ (2,3), the present study
was designed to investigate whether there are perivascular nerves
innervated in microvessels and neovessels.
Perivascular nerves play an important role in maintenance
and regulation of vascular tone and regional blood ﬂow alongnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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artery, are innervated by various perivascular nerves including
sympathetic adrenergic nerves and non-adrenergic non-cholin-
ergic nerves, which include calcitonin gene-related peptide
(CGRP) containing nerves (CGRPergic nerves) (1) and nitric
oxide-containing nerves (5). Recently, we demonstrated that
innervation of CGRPergic nerves and neuropeptide Y (NPY)-
containing sympathetic adrenergic nerves in rat mesenteric
resistance arteries was markedly reduced by topical application
of phenol in vivo and that nerve growth factor (NGF) facilitates
reinnervation of both types of nerves (6). Some reports have
shown that peripheral nerves such as the chorda tympani, lingual
nerves (7) and motor neurons in hypoglossal nerves (8) could
regenerate with new processes if they are supplied with growth-
promoting substrates. There are a few reports that adrenergic
neurons and sensory neurons are involved in angiogenesis (9,10).
However, it is still unknown whether neovessels resulted from
angiogenesis have innervation of perivascular nerves, and it re-
mains unclear whether NGF has neurotrophic effects on periph-
eral nerves of neovessels.
Therefore, the present study was designed to investigate
whether there are perivascular nerves, which are innervated in
microvessels of themouse adipose tissue and neovessels derived by
Matrigel technique. Furthermore, we examined whether NGF have
an ability to exert a promotive effect on perivascular nerve inner-
vation in neovessels of Matrigel plugs.2. Materials and methods
2.1. Experimental animals
Five-week-old BALB/c Cr Slc mouse (purchased from Shimizu
Experimental Animals, Shizuoka, Japan) were used in this study.
The animals were given food and water ad libitum. They were
housed in the Animal Research Center of Okayama University at a
controlled ambient temperature of 22 C with 50 ± 10% relative
humidity and with a 12-h light/12-h dark cycle (lights on at 8:00
AM). This study was carried out in accordance with the Guide-
lines for Animal Experiments at Okayama University Advanced
Science Research Center, Japanese Government Animal Protection
and Management Law No. 115 and Japanese Government Notiﬁ-
cation on Feeding and Safekeeping of Animals No. 6. Every effort
was made to minimize the number of animals used and their
suffering.2.2. Animal treatments and experimental protocols
The Matrigel, which is a basement membrane component
mixture, has been highly useful in various studies including in vivo
angiogenesis assays, 3D cell culture and cell invasion andmigration
assays (11e15). In this study, therefore, Growth Factor Reduced
(GFR) CorningMatrigel Matrix (Cat. Nos. 354230) with adding basic
ﬁbroblast growth factor (bFGF) and heparin as an angiogenic
growth factor was employed to derive neovessels and investigate
the effects of NGF on innervation of neovessels. Under anesthesia
with sodium pentobarbital (50 mg/kg, intraperitoneally), 500 mL of
GFR Matrigel, which was supplemented with bFGF (1 ng/mL) and
heparin (50 units/mL) in liquid form at 4 C, was bilaterally injected
into the ﬂank subcutaneous tissue of each mouse. After the in-
jections of Matrigel, the animals were transferred into individual
cages in the temperature-controlled room, and the animals were
killed by deep anesthesia on Day 7, 10, 14, 17 and 21 for use in the
experiments described below.2.3. Tissue processing
The animals treated were anesthetized with a large dose of
sodium pentobarbital (50 mg/kg, intraperitoneally). The dorsal
subcutaneous adipose tissue including Matrigel was surgically
removed and immersion-ﬁxed in the Zamboni solution (2% para-
formaldehyde and 15% picric acid in 0.15 M phosphate buffer) for
48 h. After ﬁxation, the specimens were repeatedly rinsed in
phosphate-buffered saline (PBS) and prepared for immunohisto-
chemical study as either whole mount or parafﬁn sections.2.4. Immunohistochemical study of whole mount tissue
After ﬁxation, the dorsal subcutaneous adipose tissue was
repeatedly rinsed in phosphate-buffered saline (PBS), immersed
in PBS containing 0.5% TritonX-100 overnight, and incubated
with PBS containing normal goat serum (1:100) for 60 min. The
tissue was then incubated in rabbit polyclonal anti-PGP 9.5 IgG
(NeoMarkers Inc., Fremont, CA) at a dilution of 1:100 or rabbit
polyclonal anti-CGRP antiserum (Biogenesis Ltd., Oxford, UK) at a
dilution of 1:300 or rabbit polyclonal anti-neuropeptide Y (NPY)
antiserum (Phoenix Pharmaceuticals Inc., Belmont, CA) at a
dilution of 1:300 or rabbit polyclonal anti-tyrosine hydroxylase
(TH) IgG (Chemicon international, Inc., Temecula, CA) at a dilu-
tion of 1:200 for 72 h at 4 C. After the incubation, the adipose
tissue was washed in PBS and the sites of antigeneantibody re-
action were detected by incubation with ﬂuorescein-5-
isothiocyanate (FITC)-labeled goat anti-rabbit IgG (ICN Pharma-
ceuticals, Inc., Aurora, OH) at a dilution of 1:100 for 60 min at
4 C. Thereafter, the tissue was thoroughly washed in PBS,
mounted on a slide, cover-slipped with glycerol/PBS (2: 1 v/v)
and observed under a confocal laser scanning microscope
(CLSM510, Carl Zeiss, Tokyo, Japan) in Okayama University
Medical School Central Research Laboratory.2.5. Immunostaining of parafﬁn sections
The Matrigel were dehydrated, embedded in parafﬁn and cut
thin sections (50 mm thick). After deparafﬁnization and rehydra-
tion, the sections were incubated with PBS containing normal goat
serum (1:100) for 60 min. The sections were then incubated in
rabbit polyclonal anti-PGP 9.5 IgG (NeoMarkers Inc., Fremont, CA)
at a dilution of 1:100 or rabbit polyclonal anti-CGRP antiserum
(Biogenesis Ltd., Oxford, UK) at a dilution of 1:300 or rabbit poly-
clonal anti-NPY antiserum (Phoenix Pharmaceuticals Inc., Belmont,
CA) at a dilution of 1:300 or rabbit polyclonal anti-TH IgG (Chem-
icon international, Inc., Temecula, CA) and rabbit monoclonal anti-
a-smooth muscle actin (a-SMA) FITC conjugate IgG (Sigma Aldrich
Japan, Tokyo, Japan) at a dilution of 1:300 for 72 h at 4 C. After the
incubation, the sections were washed in PBS and the sites of anti-
geneantibody reaction were detected by incubation with ﬂuores-
cein-5-isothiocyanate (FITC)-labeled goat anti-rabbit IgG (ICN
Pharmaceuticals, Inc., Aurora, OH) at a dilution of 1:100 for 60 min
at 4 C. Thereafter, the sections were thoroughly washed in PBS,
mounted on a slide, cover-slipped with glycerol/PBS (2: 1 v/v) and
observed under a confocal laser scanning microscope (CLSM510,
Carl Zeiss, Tokyo, Japan) in Okayama University Medical School
Central Research Laboratory.
The perivascular nerve length and microvessel area were
analyzed with a computer using the Image J 1.49v software pro-
gram (National Institutes of Health, USA). The perivascular nerve
length per microvessel area in 3 different ﬁelds was analyzed for
each sample.
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The Matrigel were dehydrated, embedded in parafﬁn and cut
thin sections (7 mm thick). Then, the sections were counter
stained with Mayer's hematoxylin. After rinsing with distilled
water, the sections were dehydrated, cleared in xylene, and
mounted gelatin-coated slides and cover-slipped with Entellan
for conventional light microscopic observation. Immunohisto-
chemical analysis revealed that almost all of the cells that had
entered the Matrigel were endothelial cells. The vessel number
per low-power ﬁeld in 3 different ﬁelds was counted for each
sample.2.7. NGF administration
A micro-osmotic pump (model 1003D, 1007D, 1002; Alzet, Alza,
Palo Alto, CA) containing NGF (Sigma Aldrich Japan, Tokyo, Japan)
or saline was subcutaneously implanted in the abdominal area on
Day 7 after the injections of Matrigel. Rate of NGF administration
was modiﬁed according to methods of previous studies (6,16). NGF
was intraperitoneally administered at a rate of 20 or 40 ng/h for a
period of 3, 7, 10, and 14 days. NGF, which was dissolved in sterile
saline, or sterile saline was injected into an Alzet osmotic micro-Fig. 1. Representative confocal laser micrographs showing the distribution of Protein Gene
calcitonin gene-related peptide (CGRP) (D)-like immunoreactive (LI) ﬁbers in microvesselspump. Control animals were implanted with the micro-pump
containing sterile saline alone.2.8. Statistical analysis
All data are expressed as the mean ± S.E.M. Analysis of variance
(ANOVA) followed by the Tukey's test was used to determine sta-
tistical signiﬁcance where appropriate. A value of P < 0.05 was
considered statistically signiﬁcant.3. Results
3.1. Distribution of perivascular nerves in microvessels of mouse
adipose tissues
As shown in Fig.1A, PGP 9.5-like immunoreactive (LI), which is a
speciﬁc marker for nerve tissue, ﬁbers were observed in micro-
vessels (15 mm outer diameters) of adipose tissues. The distribution
of PGP 9.5-LI ﬁbers was found in thinner vessels (less than 15 mm),
indicating that perivascular nerves innervate microvessels of adi-
pose tissues.
As shown in Fig. 1, distributions of NPY-LI (Fig. 1B) and TH-LI
(Fig. 1C) ﬁbers were observed in 15 mm outer diameter vessels ofProduct (PGP) 9.5 (A), neuropeptide Y (NPY) (B), tyrosine hydroxylase (TH) (C), and
of mouse adipose tissue. Scale bars indicate 50 mm.
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distributed in the microvessels (10 mm outer diameters) of adipose
tissue.
3.2. Distribution of peripheral nerves in neovessels of Matrigel plugs
As shown in Fig. 2, Matrigel plugs injected into mice had neo-
vessels, which contained red blood cells. In neovessels within
Matrigel plugs on Day 7, 10, 14, and 17, PGP 9.5-LI ﬁbers were not
observed. However, PGP 9.5-LI ﬁbers were founded in the adven-
titial layer of neovessels on Day 21 (Figs. 2, 3A and B).
Furthermore, distribution of TH-LI ﬁbers in neovessels of
Matrigel plugs injected into mice on Day 21were observed in the
adventitial layer (Fig. 3E). However, there were no distribution of
NPY-(Fig. 3C) and CGRP-(Fig. 3D) LI ﬁbers in neovessels of Matrigel
plugs on Day 21.
3.3. Effect of NGF treatment on innervation of perivascular nerves
in neovessels of Matrigel plugs
As shown in Fig. 4, PGP 9.5-LI ﬁbers in neovessels of Matrigel
plugs in saline treated mice were observed on Day 21, but not Day
17. In NGF (40 ng/h)-treated mice, many PGP 9.5-LI ﬁbers were
observed outside of neovessels on Day 17 (10 days after NGF
administration) and Day 21(14 days after NGF administration)
(Fig. 4). However, there was no change in the innervation of mice
treated with a low dose of NGF (20 ng/h)-, compared to that ofFig. 2. Representative confocal laser micrographs showing Protein Gene Product (PGP) 9.5-l
heads indicate neovessels and arrows in Day 21 indicate PGP 9.5-LI nerve ﬁbers. A horizonsaline-treated mice (data not shown). As shown in Fig. 5, on Day 17
and 21, the length of PGP 9.5-LI ﬁbers in neovessels of the NGF
(40 ng/h)-treated mice was signiﬁcantly longer than saline-treated
mice. Furthermore, as shown in Fig. 6A and B, TH-LI ﬁbers
distributed neovessels of Matrigel plugs on Day 21 after saline
(Fig. 6A) or NGF (Fig. 6B) treatment. However, distribution of NPY-
and CGRP-LI ﬁbers were not observed (data not shown). Also, no
change in the density of perivascular nerve innervation was found
in the distal small branch of the mesenteric artery between saline
treated mice and NGF-treated mice (data not shown).
3.4. Effect of NGF treatment on density of neovessels within
Matrigel plugs
As shown in Fig. 7, in NGF-treated mice on Day 14 after NGF
treatment, density of neovessels withinMatrigel plugs were similar
to those in saline-treated mice. There was no signiﬁcant difference
in neovessel density within Matrigel plugs between saline- and
NGF-treated mice.
3.5. Effect of NGF on distribution of vascular smooth muscle cells in
neovessels of Matrigel plugs
As shown Fig. 8, the density of vascular smooth muscle cells (a-
SMA immunopositive cells) in neovessels of Matrigel plugs in NGF-
treated mice (Fig. 8B) was higher than that in saline-treated mice
(Fig. 8A).ike immunoreactive (LI) ﬁbers in neovessels of Matrigel plugs injected into mice. Arrow
tal bar in the right lower corner of each panel indicates 20 mm.
Fig. 3. Representative confocal laser micrographs showing Protein Gene Product (PGP) 9.5 (A, B), neuropeptide Y (NPY) (C), calcitonin gene-related peptide (CGRP) (D), and tyrosine
hydroxylase (TH) (E)-like immunoreactive (LI) ﬁbers in neovessels of Matrigel plugs on Day 21 after Matrigel injection in mice. Arrow heads indicate neovessels and arrows indicate
PGP 9.5 (A, B) or TH (E)-LI nerve ﬁbers. A horizontal bar in the left lower corner of each panel indicates 20 mm.
Fig. 4. Representative confocal laser micrographs showing Protein Gene Product (PGP) 9.5-like immunoreactive (LI) nerve ﬁbers in neovessels of Matrigel plugs after nerve growth
factor (NGF) or saline treatment in mice. Arrow heads indicate neovessels and arrows indicate PGP 9.5-LI-ﬁbers. A horizontal bar in the left lower corner of each panel indicates
20 mm. Day 10, 14, 17, and 21 indicate images of 3, 7, 10, and 14 days after saline or NGF administration, respectively.
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The present study is the ﬁrst to demonstrate that the distribu-
tion of perivascular nerves, which are PGP 9.5-immunopositive
nerve ﬁbers, in microvessels of mouse adipose tissues. Further-
more, the present study demonstrated that dense NPY- or TH-
immunopositive adrenergic nerve ﬁbers and CGRP-
immunopositive nerve ﬁbers distributed outside of the micro-
vessels of mouse adipose tissues. The postganglionic sympathetic
adrenergic nerves have been shown to constitute the important
efferent pathway for neural control of vascular tone (3). The neu-
ropeptide NPY is synthesized in sympathetic ganglion cells and
axonally transported to postganglionic sympathetic nerve endings
and stored in varicosities, where it is colocalized with the adren-
ergic transmitter norepinephrine (17e19). The rate-limiting
enzyme of norepinephrine, TH, is synthesized in sympathetic
ganglion cells and axonally transported to the varicosities in the
adrenergic nerve endings (20). These notions imply that NPY- and
TH-LI-containing nerves are the postganglionic sympatheticFig. 6. Representative confocal laser micrographs showing tyrosine hydroxylase (TH)-like-im
days (Day 21) after saline (A) or NGF (B) treatment in mice. Scale bars indicate 20 mm.nerves. In the present study, it was found that microvessels with
approximate 10-mmouter diameter had distribution of perivascular
NPY-LI and TH-LI nerve ﬁbers. Therefore, it is likely that micro-
vessels in the mouse adipose tissue have distribution and inner-
vation of perivascular sympathetic adrenergic nerves.
CGRP is well known to be a vasodilator neurotransmitter for
non-adrenergic non-cholinergic nerves (1). When perivascular
CGRPergic nerves are electrically stimulated, the neurotransmitter
CGRP is released from the nerves and activates CGRP receptors on
vascular smooth muscle cells, causing potent vasodilatation (1,21).
In the present immunohistochemical study, microvessels in the
mouse adipose tissue were innervated by perivascular CGRP-LI
nerve ﬁbers, suggesting that CGRPergic nerves acts as a vasodi-
lator nerves in microvessels. Taken together, it appears that many
types of perivascular nerves innervate microvessels of mouse adi-
pose tissue to regulate vascular tone.
The present study demonstrated that PGP 9.5-LI nerve ﬁbers
were not observed in neovessels of Matrigel plugs for 17 days (Day
17), while on Day 21, PGP 9.5-LI nerve ﬁbers were conﬁrmed in the
adventitial layer of neovessels. These ﬁndings suggest that neo-
vessels have perivascular innervation as microvessels of mouse
adipose tissue do. It is reported that neovessels, which are imma-
ture vessels, have no or few perivascular innervation (22). The
present ﬁndings that there was no perivascular nerve for 17 days
after injection of Matrigel plugs suggest that perivascular nerves
innervate when neovessels became mature. Furthermore, it should
be noted that on Day 21, when PGP 9.5-LI nerves were found in
neovessels of Matrigel plugs, only TH-LI nerves, but not NPY-LI and
CGRP-LI nerves, appeared in neovessels. This ﬁnding indicates that
the distribution of PGP 9.5-LI nerves in neovessels is almost con-
sisted of that of TH-LI nerves. Therefore, it is very likely that
innervation of TH-LI nerves precedes NPY-LI and CGRP-LI nerves to
maintain vascular tone and regulate tissue blood ﬂow in matured
neovessels. Since TH is a rate-limiting enzyme for synthesis of
adrenergic transmitter norepinephrine, it is reasonable that the
ﬁrst appearance of perivascular nerves is adrenergic TH-LI nerves.
NGF was the ﬁrst protein discovered in the family of neuro-
trophins (23,24). NGF is produced in tissues innervated by neurons
and transported from nerve endings to cell bodies and is an auto-
crine factor for sympathetic nerves (25). Additionally, Hasan et al.munoreactive (LI)-ﬁbers in neovessels (cross-sectioned vessel) of Matrigel plugs on 14
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Fig. 7. Effect of nerve growth factor (NGF, 40 ng/h) treatment on neovessel density of Matrigel plugs in mice. Each bar indicates the mean ± S.E.M. Day 10, 14, 17, and 21 indicate days
after Matrigel injection.
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synthesize and secrete pro-NGF protein. NGF levels in target tissues
have been shown to correlate with the density of sympathetic
innervation (26,27). Our previous study demonstrated that NGF
facilitated redistribution of adrenergic and non-adrenergic non-
cholinergic perivascular nerves injured by topical phenol applica-
tion in rat mesenteric arteries (28), suggesting that NGF has a po-
tential activity to facilitate perivascular innervation.
The present study showed that NGF treatment facilitated peri-
vascular nerve innervation in neovessels of Matrigel plugs earlier
than saline-treated mice, while there was no change in the density
of neovessels between saline-treated and NGF-treated mice. These
results suggest that NGF promotes the distribution of perivascular
nerve ﬁbers to neovessels with increasingmatured vessels. NGF has
been shown to promote a dose-dependent increase in TH mRNA
and TH protein in cultured newborn rat superior cervical ganglia
cell neurons and induces TH expression in PC12 cells. In addition toFig. 8. Representative confocal laser micrographs showing a-smooth muscle actin immunop
growth factor (NGF) (B) treatment in mice. Scale bars indicate 20 mm.these studies, it is well established that NGF is required for the
survival of embryonic sympathetic neurons in vivo (29). NGF is
crucial for ﬁnal target innervation and retrograde survival signaling
(30), suggesting that exogenously administered NGF can facilitate
nerve growth and TH expression. This notion may explain the
present ﬁndings that the exogenous administration of NGF initially
facilitated the distribution of perivascular adrenergic TH-LI-nerve
ﬁbers.
Recent studies revealed that NGF also modulates vascular cell
functions and has angiogenesis properties in vivo (31). It has been
reported that NGF plays a functional role in reparative neo-
vascularization (32). Furthermore, supplementation of NGF has
been shown to promote angiogenesis and arteriogenesis, thereby
accelerating hemodynamic recovery (33). However, the present
study showed that there was no signiﬁcant increase in neovessel
density within Matrigel plugs in NGF-treated mice. This ﬁnding
suggests that NGF has no and/or little effect on angiogenesis inositive cells in neovessels of Matrigel plugs on 14 days (Day 21) after saline (A) or nerve
M. Goda et al. / Journal of Pharmacological Sciences 131 (2016) 251e258258Matrigel plugs. Also, it is unlikely that the angiogenetic effect of
NGF is involved in facilitatory effect of NGF on perivascular inner-
vation in neovessels. In contrast, the present study showed that
NGF treatment increased the density of vascular smooth muscle
cells in neovessels of Matrigel plugs. This ﬁnding suggests that NGF
facilitate the distribution of vascular smooth muscle cells to neo-
vessels of Matrigel plugs. This is supported by the ﬁnding of
Donovan et al. (34), who reported that NGF induces migration of
cultured human smoothmuscle cells. Additionally, the sympathetic
adrenergic nerves have been shown to have a trophic inﬂuence on
the smooth muscle cells (4). Taken together, it seems likely that
NGF facilitates perivascular adrenergic innervation and migration
of smooth muscle cells to neovessels, thereby resulting in matured
vessels.
In conclusion, the present ﬁndings suggest that themicrovessels
had innervation of perivascular adrenergic and CGRPergic nerves,
which play an important role in the maintenance and regulation of
blood ﬂow. It is also suggested that neovessels are innervated by
perivascular nerves as neovessels mature and that NGF accelerates
innervation of perivascular nerves, ﬁrstly adrenergic nerves, to
neovessels.
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